GHIT Fund 1st Anniversary Event -Global Health R&D Showcase-

The GHIT Fund celebrated the first anniversary of its inauguration with the event “Global Health R&D Showcase,” in Tokyo, Japan, on June 6, 2014. Over 350 attendees, from diverse sectors including the government, private sectors, public sectors, academia, NGOs/NPOs, and media journalists, participated in the event. The event began with Dr. Peter Piot (Director of the London School of Hygiene & Tropical Medicine, former Executive Director of UNAIDS, and current board member of the GHIT Fund) providing a keynote presentation on Japan’s history of public health and eradication of infectious and parasitic diseases after the second World War. Dr. Piot also noted Japan’s strong leadership in the global health arena, referring to the Okinawa Infectious Diseases Initiative at the Kyushu-Okinawa G8 Summit in 2000. Indeed, Japan was the first among industrialized nations to put global health on the agenda.

The panel discussion, presented by leaders from Japanese pharmaceutical companies and global health organizations tackling neglected diseases, focused on current challenges and future opportunities in global health R&D, as well as how Japanese organizations could potentially impact global health by utilizing their unique technology, innovation, and insights.

Part1:Opening Remarks - Keynote Presentation

Part2:Panel Discussion - Closing Remarks


Opening Remarks

    Dr. BT Slingsby, GHIT Fund CEO
  • Dr. BT Slingsby

    CEO and Executive Director, GHIT Fund

Keynote Presentation

    Dr. Peter Piot,
  • Dr. Peter Piot

    Director of London School of Hygiene and Tropical Medicine Former Executive Director of UNAIDS

Panel -Portfolio of Japan's Innovation for global health-


    Mr. Yasuchika Hasegawa,
  • Mr. Yasuchika Hasegawa

    President and CEO,Takeda Pharmaceutical Company Limited.
    Dr. David Reddy,
  • Dr. David Reddy

    CEO,Medicines for Malaria Venture(MMV)
    Mr. Haruo Naito,
  • Dr. Haruo Naito

    President and CEO, Eisai Co., Ltd.
    Program Agenda
  • Dr. Bernard Pécoul

    Executive Director, Drugs for Neglected Diseases initiative (DNDi)
    Mr. Masafumi Nogimori,
  • Mr. Masafumi Nogimori

    Chairman of the Board and Representative Director of Astellas Pharma Inc.
    Dr. Trevor Mundel,
  • Dr. Trevor Mundel

    President of the Global Health Program, Bill & Melinda Gates Foundation(BMGF)


    Dr. Trevor Mundel,
  • Ms. Aiko Doden

    Senior Commentator, NHK.

Closing Remarks

    Dr. Kiyoshi Kurokawa,
  • Dr. Kiyoshi Kurokawa

    GHIT Fund Chair of the Board

* Panelist’s title is as of June 6, 2014.